Advertisement
Home »

SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.

Jan 22, 2024

ABOUT THE EXPERTS

  • Aimin Jiang

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.

    Ying Liu

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.

    Baohua Zhu

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.

    Yu Fang

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.

    Le Qu

    Department of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.

    Qiwei Yang

    Depanrtment of Urology, The Third Affiliated Hospital of Naval Military Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China; Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

    Peng Luo

    Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: luopeng@smu.edu.cn.

    Chen Cai

    Department of Special Clinic, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China. Electronic address: 13818585128@163.com.

    Linhui Wang

    Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China. Electronic address: wanglinhui@smmu.edu.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement